OBJECTIVES: After completing this activity, the participant should be able to: State current recommendations for GLP-1 receptor agonist use in the management of type 2 diabetes
It has gained popularity as a regenerative wellness and integrative veterinary medicine to treat conditions such as chronic inflammation, delayed healing, orthopedic injuries, digestive issues, and recovery support
While cagrilintide has not yet been approved for therapeutic use, its mechanisms of action have inspired further exploration in research settings, particularly in preclinical and early-phase clinical studies focused on gastrointestinal and metabolic endpoints
Hormonal Control of Substrate Cycling in Humans
While this doesnt directly translate to appetite loss like the GLP-1 agonist effect, it does help improve how the body uses food
It crosses the blood-brain barrier efficiently and influences vascular physiology to improve cerebral blood flow, aiding neuronal communication and cognitive functions